Seeing Is Believing
ACAD is currently covered by 20 analysts with an average price target of $31.38. This is a potential upside of $6.06 (23.93%) from yesterday's end of day stock price of $25.32.
ACADIA Pharmaceuticals's activity chart (see below) currently has 405 price targets and 326 ratings on display. The stock rating distribution of ACAD is 70% BUY, 28.75% HOLD and 1.25% SELL.
Analysts average stock forecasts to be materialized ratio is 65.76% with an average time for these price targets to be met of 228.03 days.
Highest price target for ACAD is $38, Lowest price target is $17, average price target is $27.58.
Most recent stock forecast was given by JASON BUTLER from JMP on 07-Aug-2025. First documented stock forecast 06-May-2013.
Currently out of the existing stock ratings of ACAD, 56 are a BUY (70%), 23 are a HOLD (28.75%), 1 are a SELL (1.25%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$38
$12.26 (47.63%)
$37
18 days ago
(07-Aug-2025)
9/17 (52.94%)
$13.6 (55.74%)
238
Hold
$24
$-1.74 (-6.76%)
$23
18 days ago
(07-Aug-2025)
9/13 (69.23%)
$-0.4 (-1.64%)
171
Sell
$17
$-8.74 (-33.95%)
$12
18 days ago
(07-Aug-2025)
4/7 (57.14%)
$-7.4 (-30.33%)
186
Buy
$34
$8.26 (32.09%)
$30
1 months 1 days ago
(24-Jul-2025)
6/10 (60%)
$10.95 (47.51%)
106
Buy
$32
$6.26 (24.32%)
$32
1 months 30 days ago
(26-Jun-2025)
7/23 (30.43%)
$9.79 (44.08%)
118
What is ACAD (ACADIA Pharmaceuticals) average time for price targets to be met?
Which analyst has the current highest performing score on ACAD (ACADIA Pharmaceuticals) with a proven track record?
Which analyst has the most public recommendations on ACAD (ACADIA Pharmaceuticals)?
Which analyst is the currently most bullish on ACAD (ACADIA Pharmaceuticals)?
Which analyst is the currently most reserved on ACAD (ACADIA Pharmaceuticals)?